Login / Signup

Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B.

Paola FisicaroValeria BariliBarbara MontaniniGreta AcerbiManuela FerracinFrancesca GuerrieriDebora SalernoCarolina BoniMarco MassariM Cristina CavalloGlenda GrossiTiziana GiubertiPietro LamperticoGabriele MissaleMassimo LevreroSimone OttonelloCarlo Ferrari
Published in: Nature medicine (2017)
Hepatitis B virus (HBV)-specific CD8 T cells are functionally exhausted in chronic hepatitis B infection, and this condition can be corrected only partially through the modulation of inhibitory pathways, which suggests that a more complex molecular interplay underlies T cell exhaustion. To gain broader insight into this process and identify additional targets for the restoration of T cell function, we compared the transcriptome profiles of HBV-specific CD8 T cells from patients with acute and chronic disease with those of HBV-specific CD8 T cells from patients able to resolve HBV infection spontaneously and influenza (FLU)-specific CD8 T cells from healthy participants. The results indicate that exhausted HBV-specific CD8 T cells are markedly impaired at multiple levels and show substantial downregulation of various cellular processes centered on extensive mitochondrial alterations. A notable improvement of mitochondrial and antiviral CD8 functions was elicited by mitochondrion-targeted antioxidants, which suggests a central role for reactive oxygen species (ROS) in T cell exhaustion. Thus, mitochondria represent promising targets for novel reconstitution therapies to treat chronic hepatitis B infection.
Keyphrases
  • hepatitis b virus
  • liver failure
  • reactive oxygen species
  • end stage renal disease
  • chronic kidney disease
  • dna damage
  • cancer therapy
  • newly diagnosed
  • cell proliferation
  • rna seq
  • signaling pathway
  • single molecule